BIOMAT Database Logo BIOMAT Database Logo

Immunological studies in onchocercosis patients. 1977

F Merino, and A Brand

The immunological profile of onchocercosis patients from an endemic region in Venezuela was studied. The sample was made up of patients suffering from onchocercosis and undergoing treatment, persons previously treated and apparently cured of the disease, and a group of apparently healthy individuals from the same area. The results obtained indicate that during the course of the disease the immunological apparatus suffers only slight modifications since no great variations were found in the immunoglobulin levels, the third component of the complement, the reactivity to DNCB, or the response of peripheral blood lymphocytes to mitogens. When under treatment, the levels of serum IgG and IgM are increased and there is a decrease in C3 levels. The slight modifications found can be attributed to the low severity of the disease as only one patient of those studied presented clinical manifestations ascribable to the disease (onchocercoma).

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009855 Onchocerciasis Infection with nematodes of the genus ONCHOCERCA. Characteristics include the presence of firm subcutaneous nodules filled with adult worms, PRURITUS, and ocular lesions. Onchocerciases
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D004137 Dinitrochlorobenzene A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds. 1-Chloro-2,4-Dinitrobenzene,2,4-Dinitrochlorobenzene,Benzene, 1-Chloro-2,4-Dinitro-,Chlorodinitrobenzene,DNCB,1 Chloro 2,4 Dinitrobenzene,2,4 Dinitrochlorobenzene

Related Publications

F Merino, and A Brand
[ONCHOCERCOSIS].
February 1964, Zeitschrift fur Haut- und Geschlechtskrankheiten,
F Merino, and A Brand
[Onchocercosis].
January 1961, Revista de sanidad militar,
F Merino, and A Brand
[Onchocercosis].
October 1980, MMW, Munchener medizinische Wochenschrift,
F Merino, and A Brand
[Onchocercosis in animals].
January 1966, Berliner und Munchener tierarztliche Wochenschrift,
F Merino, and A Brand
[Onchocercosis in Angola].
September 1950, Jornal do medico,
F Merino, and A Brand
Immunological studies in patients with oligospermia.
October 1989, Fertility and sterility,
F Merino, and A Brand
[Immunological studies in patients with arteriosclerosis].
January 1972, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
F Merino, and A Brand
Immunological studies in methadone maintained patients.
April 1977, The International journal of the addictions,
F Merino, and A Brand
Eye complications in onchocercosis.
June 1954, Documenta de medicina geographica et tropica,
F Merino, and A Brand
Onchocercosis in North America.
May 1933, California and western medicine,
Copied contents to your clipboard!